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Background
Plasma from HIV-1 seropositive individuals show a range
of specificities from variant specific to broad cross-neu-
tralizing. The plasma also show different kinetics of neu-
tralization which may be linked to their specificity. The
properties may be a consequence of being a polyclonal
mixture of antibodies. Isolating monoclonal antibodies
from these people would help to resolve these issues.
Methods
Panels of primary isolates of HIV-1 subtypes A, B, C and
circulating recombinant form CRF02_AG were prepared
in mitogen stimulated PBMCs. Neutralization assays were
performed with different lengths of incubation (1 h vs. 24
h), absorption (1 h vs. 24 h) and culture phases (7 days or
14 days for PBMCs and 2 days for cell lines). Plasma from
patients infected with either HIV-1 subtype C or
CRF02_AG and attending the HIV clinic in Antwerp were
screened in PBMC neutralization assays. Monoclonal
antibodies were then isolated from memory B cells of
individuals whose plasma cross-neutralized strains from
multiple subtypes in a high throughput HOS cell based
assay using pseudoviruses.
Results
The original donors' plasma were active against relatively
resistant HIV-1 isolates in assays with extended incuba-
tion phases. In contrast, the monoclonal antibodies were
active against relatively sensitive isolates in assays with
extended absorption phases. Pseudoviruses had a ten-
dency to be easier neutralized compared to their primary
viruses.
Conclusion
The neutralizing properties of the monoclonal antibodies
do not reflect those of the plasma from the original
donors. Either the method of selecting the monoclonals
or the proportion of monoclonals isolated may be a prob-
lem. Mixtures of monoclonals may be required for activity
against the relatively resistant isolates and the amount of
specific antibodies in the plasma is unknown. Alterna-
tively, there may be a discrepancy between specificities of
the bone marrow plasma cells and the circulating memory
B cells.
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